While the mechanism of CCL13 in modulating inflammatory responses in AD pathogenesis is not clear, growing evidence suggests that CCL13 and IL4 are closely linked to Th2 mediated immune responses and the activation of eosinophils [53, 54]. The gene discussed is CCL13; the disease is Alzheimer disease.